Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity
Author(s) -
Ann Hellström,
Anders K. Nilsson,
Dirk Wackernagel,
Aldina Pivodic,
Mireille Vanpée,
Ulrika Sjöbom,
Gunnel Hellgren,
Boubou Hallberg,
Magnus Domellöf,
Susanna Klevebro,
William Hellström,
Mats Andersson,
AnnaMy Lund,
Chatarina Löfqvist,
Anders Elfvin,
Karin Sävman,
Ingrid HansenPupp,
AnnaLena Hård,
Lois E.H. Smith,
David Ley
Publication year - 2021
Publication title -
jama pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.004
H-Index - 183
eISSN - 2168-6211
pISSN - 2168-6203
DOI - 10.1001/jamapediatrics.2020.5653
Subject(s) - medicine , retinopathy of prematurity , gestational age , pediatrics , docosahexaenoic acid , enteral administration , randomized controlled trial , population , gestation , parenteral nutrition , pregnancy , fatty acid , polyunsaturated fatty acid , genetics , chemistry , environmental health , organic chemistry , biology
Lack of arachidonic acid (AA) and docosahexaenoic acid (DHA) after extremely preterm birth may contribute to preterm morbidity, including retinopathy of prematurity (ROP).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom